 RALEIGH, NC ACCESSWIRE July 28, 2020 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the U.S. Patent and Trademark Office USPTO issued U.S. Pat. No. 10,723,763, titled, Use of Tight Junction Antagonists in the Treatment of Acute Lung Injury and Acute Respiratory Distress, relating to its proprietary investigational agent, larazotide. 